Pharmacokinetic Interactions between Cardiovascular Medicines and Plant Products

被引：10

作者：

Costache, Irina-Iuliana ^{[1
,2
]}

Miron, Anca ^{[3
]}

Hancianu, Monica ^{[3
]}

Aursulesei, Viviana ^{[1
,2
]}

Costache, Alexandru Dan ^{[1
]}

Aprotosoaie, Ana Clara ^{[3
]}

机构：

[1] Grigore T Popa Univ Med & Pharm Iasi, Fac Med, Iasi 700115, Romania

[2] Sf Spiridon Univ Hosp, Iasi 700111, Romania

[3] Grigore T Popa Univ Med & Pharm Iasi, Fac Pharm, Iasi 700115, Romania

来源：

CARDIOVASCULAR THERAPEUTICS | 2019年 / 2019卷

关键词：

ST-JOHNS-WORT; INCREASES SERUM CONCENTRATIONS; JUICE-FELODIPINE INTERACTION; HERB-DRUG INTERACTIONS; GRAPEFRUIT JUICE; GINKGO-BILOBA; GREEN TEA; PLASMA-CONCENTRATIONS; DIETARY-SUPPLEMENTS; P-GLYCOPROTEIN;

D O I：

10.1155/2019/9402781

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The growing use of plant products among patients with cardiovascular pharmacotherapy raises the concerns about their potential interactions with conventional cardiovascular medicines. Plant products can influence pharmacokinetics or/and pharmacological activity of coadministered drugs and some of these interactions may lead to unexpected clinical outcomes. Numerous studies and case reports showed various pharmacokinetic interactions that are characterized by a high degree of unpredictability. This review highlights the pharmacokinetic clinically relevant interactions between major conventional cardiovascular medicines and plant products with an emphasis on their putative mechanisms, drawbacks of herbal products use, and the perspectives for further well-designed studies.

引用

页数：19

共 50 条

[21] PHARMACOKINETIC INTERACTIONS BETWEEN FELODIPINE AND METOPROLOL
SMITH, SR
WILKINS, MR
JACK, DB
KENDALL, MJ
LAUGHER, S
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 31 (05) : 575 - 578
[22] Pharmacokinetic interactions between statins and fibrates
Corsini, A
Bellosta, S
Davidson, MH
AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (9A): : 44K - 49K
[23] Pharmacogenetic-Pharmacokinetic Interactions in Drug Marketing Authorization Applications via the European Medicines Agency Between 2014 and 2017
Maliepaard, Marc
Toiviainen, Timi
De Bruin, Marie L.
Meulendijks, Didier
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (02) : 338 - 349
[24] Drug interactions between herbal and prescription medicines
Williamson, EM
DRUG SAFETY, 2003, 26 (15) : 1075 - 1092
[25] Herbal medicines in Brazil: pharmacokinetic profile and potential herb-drug interactions
Mazzari, Andre L. D. A.
Prieto, Jose M.
FRONTIERS IN PHARMACOLOGY, 2014, 5
[26] Drug Interactions Between Herbal and Prescription Medicines
Elizabeth M. Williamson
Drug Safety, 2003, 26 : 1075 - 1092
[27] Interactions between antiepileptic drugs and herbal medicines
Landmark, Cecilie Johannessen
Patsalos, Philip N.
BOLETIN LATINOAMERICANO Y DEL CARIBE DE PLANTAS MEDICINALES Y AROMATICAS, 2008, 7 (02): : 108 - 118
[28] Interactions of herbal products with conventional medicines and potential impact on pregnancy
Buehler, BA
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY, 2003, 68 (06) : 494 - 495
[29] Medicines for older people: assessment and transparency at the European Medicines Agency regarding cardiovascular and antithrombotic medicinal products
Cerreta, Francesca
Padrao, Andreia
Skibicka-Stepien, Izabela
Strampelli, Anna
de Orbe Izquierdo, Maria Silvia
EUROPEAN GERIATRIC MEDICINE, 2018, 9 (04) : 415 - 418
[30] An overview on safety issues of interactions between traditional herbal medicines and pharmaceutical medicines
Chan, Kelvin
BOLETIN LATINOAMERICANO Y DEL CARIBE DE PLANTAS MEDICINALES Y AROMATICAS, 2008, 7 (06): : 312 - 331

← 1 2 3 4 5 →